About Ilyas Sahin
Ilyas Sahin, MD, is an assistant professor with the division of hematology & oncology. At UF Health, he specializes in gastrointestinal oncology.
Dr. Sahin earned his medical degree from Hacettepe University Faculty of Medicine in Turkey. He then worked as postdoctoral research fellow in medical oncology at Dana-Farber Cancer Institute, Harvard Medical School.
He completed his internship at Montefiore Medical Center, Albert Einstein College of Medicine and a residency at Mount Auburn Hospital, Harvard Medical School, both in internal medicine. Most recently he completed a fellowship at Rhode Island Hospital, Brown University in hematology and oncology.
Before joining UF Health, Dr. Sahin was an assistant professor of medicine at The Warren Alpert Medical School, and a clinical hematologist/oncologist at Miriam Hospital with the Lifespan Cancer Institute.
Dr. Sahin’s research interests gave led to more than thirty research papers and abstracts. In addition to focusing on his own research which primarily focuses on cancer immunotherapy and immunotherapy resistance, he currently serves as Associate Editor for Frontiers in Oncology. His work on the role of MDM2 in immunotherapy resistance was published with multiple online news networks and it was among CDDpress journals monthly readers’ choice. Recently, he developed a novel preclinical animal model for hyperprogression, acceleration of cancer growth (more rapid than expected), which occurs in some of cancer patients receiving immunotherapy. This novel model may help understanding unusual patterns of response and/ or resistance to immunotherapies which may provide key knowledge to develop new therapies in cancer patients.
Dr. Sahin is board certified in Internal Medicine, Hematology and Medical Oncology. He is also a member of the American Society of Clinical Oncology.
HematologyAmerican Board Of Internal Medicine
Internal MedicineAmerican Board Of Internal Medicine
OncologyAmerican Board Of Internal Medicine
- Esophageal cancer
- Liver cancer – hepatocellular carcinoma
- Stomach cancer